Clinical Trials
Now Enrolling Patients for Pattern Hair Loss Study
We are currently enrolling participants in a Phase 2/3 national clinical trial evaluating our lead product candidate, VDPHL01, an investigational, proprietary, non-hormonal oral treatment for androgenetic alopecia (AGA), also known as pattern hair loss (PHL).
For more information and to find a study site, visit www.phlstudy.com.
